Advisors Asset Management, Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisors Asset Management, Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,752,179
+12.5%
22,704
+6.2%
0.06%
+18.0%
Q2 2023$2,447,178
+1.7%
21,369
+22.4%
0.05%
+2.0%
Q1 2023$2,406,374
+10.6%
17,459
+4.0%
0.05%
+8.9%
Q4 2022$2,174,871
+17.7%
16,784
+0.4%
0.04%
+15.4%
Q3 2022$1,848,000
+129.9%
16,719
+55.9%
0.04%
+160.0%
Q2 2022$804,000
-52.1%
10,721
-50.1%
0.02%
-42.3%
Q1 2022$1,678,000
-21.6%
21,485
-9.7%
0.03%
-16.1%
Q4 2021$2,141,000
-1.7%
23,780
+1.0%
0.03%
-6.1%
Q3 2021$2,178,000
+18.0%
23,551
-0.8%
0.03%
+22.2%
Q2 2021$1,846,000
+21.1%
23,742
+16.1%
0.03%
+12.5%
Q1 2021$1,524,000
-34.6%
20,446
+49.5%
0.02%
-38.5%
Q4 2020$2,331,000
+94.2%
13,675
+60.1%
0.04%
+77.3%
Q3 2020$1,200,000
+53.6%
8,542
+75.4%
0.02%
+46.7%
Q2 2020$781,000
+474.3%
4,870
+250.6%
0.02%
+400.0%
Q1 2020$136,000
-44.9%
1,389
-27.5%
0.00%
-25.0%
Q4 2019$247,000
-15.4%
1,915
-50.6%
0.00%
-20.0%
Q3 2019$292,000
-49.7%
3,875
+1.3%
0.01%
-50.0%
Q2 2019$581,000
+28.0%
3,825
+0.4%
0.01%
+25.0%
Q1 2019$454,000
+19.8%
3,811
+9.7%
0.01%0.0%
Q4 2018$379,000
-21.9%
3,473
+15.7%
0.01%0.0%
Q3 2018$485,0003,0030.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,315,000$170,397,70013.20%
EcoR1 Capital, LLC 2,999,453$388,669,12011.83%
Evolutionary Tree Capital Management, LLC 63,756$8,261,5027.93%
Tri Locum Partners LP 119,695$15,510,0006.27%
Avoro Capital Advisors LLC 3,175,000$411,416,5006.15%
Camber Capital Management LP 1,250,000$161,9755.56%
Finepoint Capital LP 131,457$17,0345.51%
ACUTA CAPITAL PARTNERS, LLC 67,500$8,746,6505.38%
Logos Global Management LP 220,000$28,507,6003.34%
AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP 33,454$3,401,6573.20%
View complete list of SAREPTA THERAPEUTICS INC shareholders